Researchers have been exploring the use of positron emission tomography (PET) imaging to detect ghrelin receptor activity
Under Kennedy, however, the FDA is in the strange position of both having to still do its jobs such as properly enforcing regulations and laws, but also soon to open the door to unproven things like peptides and stem cells, he said
Charles Mok for GLP-1 Agonist
A common concern is whether indefinite use is necessary
In this article, well explore the potential of GLP-1 patches, how they might fit into the broader treatment landscape, and what patients considering metabolic health support should know about the future of these therapies
The synergetic effect of edaravone and borneol in the rat model of ischemic stroke